Evidence map›Paper›PMID 34437584›Full record

ArticlePloS one2021

Genotypic and phenotypic diversity of Mycobacterium tuberculosis complex genotypes prevalent in West Africa.

Stephen Osei-Wusu, Isaac Darko Otchere, Portia Morgan, Abdul Basit Musah, Ishaque Mintah Siam, Diana Asandem, Theophilus Afum, Prince Asare, Adwoa Asante-Poku, Kwadwo Asamoah Kusi and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Comparative Genomic Analysis ofTropical medicine and infectious disease · 2024
    Article
  3. Review
  4. Macrophage susceptibility to infection by GhanaianFrontiers in cellular and infection microbiology · 2023
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Stephen Osei-WusuNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Isaac Darko OtchereNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Portia MorganNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Abdul Basit MusahNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Ishaque Mintah SiamNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Diana AsandemNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Theophilus AfumNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Prince AsareNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Adwoa Asante-PokuNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.ORCID 0000-0001-8929-193X
Kwadwo Asamoah KusiNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.ORCID 0000-0001-5483-9985
Sebastien GagneuxSwiss Tropical and Public Health Institute, Basel, Switzerland.
Dorothy Yeboah-ManuNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.ORCID 0000-0002-1663-6287
University of Ghana · GHSwiss Tropical and Public Health Institute · CH

Funding

Medical Research Council MR/P028071/1
6 · The paper itself

Abstract

Findings from previous comparative genomics studies of the Mycobacterium tuberculosis complex (MTBC) suggest genomic variation among the genotypes may have phenotypic implications. We investigated the diversity in the phenotypic profiles of the main prevalent MTBC genotypes in West Africa. Thirty-six whole genome sequenced drug susceptible MTBC isolates belonging to lineages 4, 5 and 6 were included in this study. The isolates were phenotypically characterized for urease activity, tween hydrolysis, Thiophen-2-Carboxylic Acid Hydrazide (TCH) susceptibility, nitric oxide production, and growth rate in both liquid (7H9) and solid media (7H11 and Löwenstein-Jensen (L-J)). Lineage 4 isolates showed the highest growth rate in both liquid (p = 0.0003) and on solid (L-J) media supplemented with glycerol (p<0.001) or pyruvate (p = 0.005). L6 isolates optimally utilized pyruvate compared to glycerol (p<0.001), whereas L5 isolates grew similarly on both media (p = 0.05). Lineage 4 isolates showed the lowest average time to positivity (TTP) (p = 0.01; Average TTP: L4 = 15days, L5 = 16.7days, L6 = 29.7days) and the highest logCFU/mL (p = 0.04; average logCFU/mL L4 = 5.9, L5 = 5.0, L6 = 4.4) on 7H11 supplemented with glycerol, but there was no significant difference in growth on 7H11 supplemented with pyruvate (p = 0.23). The highest release of nitrite was recorded for L5 isolates, followed by L4 and L6 isolates. However, the reverse was observed in the urease activity for the lineages. All isolates tested were resistant to TCH except for one L6 isolate. Comparative genomic analyses revealed several mutations that might explain the diverse phenotypic profiles of these isolates. Our findings showed significant phenotypic diversity among the MTBC lineages used for this study.

Indexed as

GenotypeMycobacterium tuberculosisPhenotypeAfrica, WesternAntitubercular AgentsGenetic VariationHumansMicrobial Sensitivity TestsPhylogenyTuberculosisWhole Genome SequencingAntitubercular Agents

Identifiers

PMID34437584
PMCPMC8389432
OpenAlexW3195044951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.